Position in BNTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$55,120,957
-$23,322,041 QoQ
Shares Held
592,380
-32.9% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#16
of 283 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names. BNTX ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
This page
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in BNTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,120,957 | 592,380 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $78,442,998 | 882,572 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $118,511,337 | 1,244,867 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $777,062,382 | 7,879,359 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $855,898,700 | 8,038,872 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $743,020,642 | 8,159,682 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $936,735,203 | 8,220,581 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $986,749,589 | 8,308,071 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $665,083,305 | 8,276,298 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $771,112,122 | 8,358,939 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $917,056,265 | 8,689,182 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $934,612,428 | 8,602,839 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $804,110,661 | 7,450,298 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $939,371,406 | 7,540,912 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $1,159,416,434 | 7,718,123 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $977,215,310 | 7,245,072 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $1,082,910,315 | 7,262,980 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $1,150,375,518 | 6,744,697 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,684,061,999 | 6,532,436 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $1,732,206,994 | 6,345,313 | Shares | Defined | 2021-10-19 | |
| 2021-06-30 | $1,439,492,204 | 6,429,749 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $735,723,528 | 6,738,012 | Shares | Defined | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||